insights_auto
Why is EDIT down 13,82%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,87 $
arrow_downward
-13,82%(-0,30) 1D
1,87 $
arrow_downward
-0,20% (-0,0038)todayPre-market
Closed: 16 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,10 $
High
2,12 $
Low
1,86 $
Mkt. cap
288,62 մլն
Avg. vol.
2,44 մլն
Volume
9,22 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
2,10 $
High
2,12 $
Low
1,86 $
Mkt. cap
288,62 մլն
Avg. vol.
2,44 մլն
Volume
9,22 հզր
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Benzinga
·
37 րոպե առաջ
Stock Market Today: Dow Jones, S&P 500 Futures Fall Ahead of Nvidia's Q3 Earnings— CBRS, AMZN, RCAT in Focus
The Motley Fool
·
1 ժամ առաջ
The S&P 500 Had Its Worst Day in Over a Year. Here's Why I'm Still Investing.
Trefis
·
2 ժամ առաջ
31 S&P 500 Stocks Just Made New 52-Week Highs
Traders Union
·
11 ժամ առաջ
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc